| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 164 |
| 1 | ETANERCEPT | 159 |
| 2 | METHOTREXATE | 143 |
| 3 | ABATACEPT | 132 |
| 4 | RITUXIMAB | 105 |
| 5 | PREDNISONE | 103 |
| 6 | HYDROXYCHLOROQUINE SULFATE | 93 |
| 7 | AZATHIOPRINE | 88 |
| 8 | MYCOPHENOLATE MOFETIL | 82 |
| 9 | ADALIMUMAB | 79 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN GROWTH HORMONE | 2 | 0.0286 |
| 1 | PENICILLAMINE | 15 | 0.0162 |
| 2 | HYDROCORTISONE VALERATE | 2 | 0.0032 |
| 3 | GOLD | 15 | 0.0026 |
| 4 | TOBRAMYCIN SOLUTION | 16 | 0.0013 |
| 5 | TOBRAMYCIN SULFATE | 16 | 0.0013 |
| 6 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 1 | 0.0011 |
| 7 | HYDROXYCHLOROQUINE SULFATE | 93 | 0.0010 |
| 8 | AZATHIOPRINE | 88 | 0.0010 |
| 9 | ABATACEPT | 132 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 162 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 143 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 132 |
| 3 | Corticosteroid [EPC] | 111 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 106 |
| 5 | Purine Antimetabolite [EPC] | 88 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 60 |
| 7 | Antirheumatic Agent [EPC] | 58 |
| 8 | Vitamin C [EPC] | 55 |
| 9 | Vitamin B12 [EPC] | 53 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Modulator [EPC] | 132 | 0.0009 |
| 1 | Purine Antimetabolite [EPC] | 88 | 0.0009 |
| 2 | Antirheumatic Agent [EPC] | 58 | 0.0005 |
| 3 | Aminosalicylate [EPC] | 44 | 0.0004 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 7 | 0.0004 |
| 5 | Aminoglycoside Antibacterial [EPC] | 16 | 0.0004 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 106 | 0.0003 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 143 | 0.0003 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |
| 9 | Tetracycline-class Drug [EPC] | 16 | 0.0002 |